Literature DB >> 6517949

Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils.

T W Doebber, M S Wu, T Y Shen.   

Abstract

Intravenous infusion of platelet activating factor into rats at doses of 5-20 nmoles/kg results in a rapid and dose-dependent increase in the plasma level of several lysosomal hydrolases, notably glucosaminidase. This hydrolase secretion occurs concomitantly with the increased vascular permeability but subsequent to the neutropenia and hypotensive responses to platelet activating factor. The glucosaminidase release in vivo does not exhibit any lasting desensitization, does not require cytochalasin B, and is quantitatively the same in rats made neutropenic with anti-neutrophil serum, and thus is different from the published in vitro degranulating effect of this lipid with neutrophils. Therefore, lysosomal hydrolase secretion may be an important pathophysiologic response to very low blood levels of platelet activating factor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6517949     DOI: 10.1016/0006-291x(84)91380-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.

Authors:  J L Wallace; B J Whittle
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

2.  Gastrointestinal damage induced by platelet-activating factor. Inhibition by the corticoid, dexamethasone.

Authors:  J L Wallace; B J Whittle
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

3.  Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat.

Authors:  J V Esplugues; B J Whittle
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

4.  Platelet activating factor: release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretion.

Authors:  T D Wardle; L Hall; L A Turnberg
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

5.  Evidence for the role of platelet-activating factor in immune complex vasculitis in the rat.

Authors:  J S Warren; D M Mandel; K J Johnson; P A Ward
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

6.  Platelet-activating factor (PAF) stimulates the PAF-synthesizing enzyme acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase and PAF synthesis in neutrophils.

Authors:  T W Doebber; M S Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Platelet-activating factor (PAF) stimulates the lysoPAF acetyltransferase in leukocyte-rich plasma: use in PAF antagonist studies.

Authors:  T W Doebber; M S Wu; A Mauriello; A Alberts
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.